8
Views
4
CrossRef citations to date
0
Altmetric
Research Article

The role of substitute therapy in the treatment of problem amphetamine use

Pages 417-429 | Published online: 12 Jul 2009

  • European Monitoring Centre for Drugs and Drug Addiction. New trends in synthetic drugs in the European Union: epidemiology and demand reduction responses. EMCDDA Insights series 1. Luxembourg: Office for Official Publications of the European Communities, 1997.
  • World Health Organization (WHO). Amphetaminetype stimulants: report from the WHO meeting on amphetamines, MDMA and other psychostimulants, Geneva, 1996. Geneva: WHO Programme on Substance Abuse, 1997.
  • UNDCP. Amphetamine-type stimulants: a global review (UNDCP Technical Series Number 3). Vienna: United Nations International Drug Control Programme, 1996.
  • UNDCP. World drug report. New York: Oxford University Press, 1997.
  • UNDCP. World drug report 2000. New York: Oxford University Press, 2000.
  • Department of Health, Drug Misuse and Dependence. Guidance on clinical management. Norwich, UK: The Stationery Office, 1999.
  • Ramsey M, Spiller J. Drug misuse declared in 1996: latest results from the British Crime Survey. London: Home Office, 1997.
  • EMCDDA. Evaluating the treatment of drug abuse in the European Union. Luxembourg: Office for Official Publications of the European Communities, 1999.
  • MacGregor S. Drugs in British society. London: Roudedge, 1989.
  • Klee H, Wright S. Amphetamine use and treatment: a study of the impediments to effective service delivery. Part 1. Access to treatment services, Blue Book Series. The Manchester Metropolitan University, Manchester: SRHSA, 1999.
  • Klee H. A new target for behavioural research-amphetamine misuse. Br J Addict 1992;87:439-46.
  • Wright S, Klee H, Reid P. Attitudes of amphetamine users to treatment services. Drugs Educ Prev Policy 1999;6:71-86.
  • Myles J. Treatment for amphetamine misuse in the United Kingdom. In: Klee H, ed. Amphetamine misuse: international perspectives on current trends. The Netherlands: Harwood Academic Publishers, 1997:69-80.
  • Wright S, Klee H. Violent crime, aggression and amphetamine. Drugs Educ Prev Policy 2001;8: 73-90.
  • Suwaki H, Fukui S, Konuma K. Methamphetamine abuse in Japan. In: Klee H, ed. Amphetamine misuse: international perspectives on current trends. The Netherlands: Harwood Academic Publishers, 1997:199-214.
  • Klee H, Reid PAmphetamine misusing groups: a feasibility study of the use of peer group leaders for drug prevention work among their associates. Central Drug Prevention Unit (CDPU) Research Report 3. London: The Home Office, 1995.
  • Klee H. The love of speed: an analysis of the enduring attraction of amphetamine sulphate for British youth. J Drug Issues (Special Edition) 1998;28:33-55.
  • Department of Health. Task force to review services for drug misusers: report of an independent review of drug treatment services in England. London: Department of Health, 1996.
  • Klee H, Wright S, Rothwell J. Amphetamine use and treatment: a study of individual and policy impediments to effective service delivery. Final Report to the Department of Health Task Force, 1997.
  • Wright S, Klee H, Reid P. Interviewing illicit drug users: observations from the field. Addict Res 1998;6:517-35.
  • Gossop M, Stewart D, Marsden J. NTORS at one year. The National Treatment Outcome Research Study: changes in substance use, health and criminal behaviours one year after intake. London: Department of Health, 1998.
  • Strang J, Sheridan J. Prescribing amphetamines to drug misusers: data from the 1995 national survey of community pharmacies in England and Wales. Addiction 1997;92:833-8.
  • Bradbeer TM, Fleming PM, Charlton P, Crichton JS. Survey of amphetamine prescribing in England and Wales. Drug Alcohol Rev 1998;17:299-304.
  • Chamaud B, Griffiths V. Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: a comparison. Drug Alcohol Depend 1998;52:79-84.
  • Pates R, Coombes N, Ford N. A pilot programme: prescribing dexamphetamine for amphetamine users. J Subst Misuse 1996;l:80-4.
  • McBride AJ, Sullivan G, Blewett AE, Morgan S. Amphetamine prescribing as a harm reduction measure: a preliminary study. Addict Res 1997;5:95-112.
  • Hendriks V. Evaluating drug-abuse treatment: current and future perspectives, In: Evaluating the treatment of drug abuse in the European Union, ch. 1. EMCDDA Scientific Monograph series no. 3. Luxembourg: EMCDDA, 1999.
  • Klee H, Wright S. Amphetamine use and treatment: a study of the impediments to effective service delivery. Fart 2. Treatment and its outcomes, Blue Book Series. The Manchester Metropolitan University, Manchester: SRHSA, 1999.
  • Klee H, Wright S, Morris J. Amphetamine users in treatment: actors associated with sustained abstinence from street drugs. Addict Res 1999;7:239-65.
  • Wright S, Klee H. A profile of amphetamine users who present to treatment and do not return. Drugs Educ Prev Policy 1999;6:227-41.
  • Klee, H, Jackson M. Illicit drug use, pregnancy and early motherhood. Blue Book Series. The Manchester Metropolitan University, Manchester: SRHSA, 1998.
  • Tetlow VA, Merrill J. Rapid determination of amphetamine stereoisomer ratios in urine by gas chromatography-mass spectroscopy. Ann Clin Biochem 1996;33:50-4.
  • Shearer J, Wodak A, Mattick RPet al. A randomised controlled trial of the feasibility of monitoring controlled prescribing of dexamphetamine. NDARC Technical Report no. 75. Sydney, Australia: National Drug and Alcohol Research Centre, 1999.
  • Strauss A, Corbin J. Basics of qualitative research. Newbury Park, CA: Sage, 1990.
  • White R. Dexamphetamine substitution in the treatment of amphetamine abuse: an initial investigation. Addiction 2000;95:229-38.
  • Mattick RF, Darke S. Drug replacement treatments: is amphetamine substitution a horse of a different colour? Drug Alcohol Rev 1995;14:389-94.
  • Lintzeris N, Holgate F, Dunlop A. Addressing dependent amphetamine use: a place for prescription. Drug Alcohol Rev 1996;15:189-95.
  • Kamieniecki G, Vincent N, Allsop S, Lintzeris N. Models of intervention and care or psychostimulant users. Monograph Series no. 32. Canberra, Australia: National Centre for Education and Training on Addiction, Commonwealth Department of Health and Family Services, 1998.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.